With advancements in the field of medicine, the knowledge gained in the field of oncology is unprecedented. However, the global burden of cancer is on rise because of increased life expectancy, population growth and also because most of the anticancer agents only give partial cure or symptomatic relief. Hence there is still scope for further research to discover breakthrough medicines for treatment of cancer. At CarcinoTM we specially focus on the development of novel anticancer agents that specifically target the most prevalent cancers world-wide – Lung cancer, breast cancer and colorectal cancer.